S&P 500 top movers: Regeneron Pharmaceuticals Inc (REGN) jumps to monthly highs above $600
|- S&P 500 Index remains on track to register strong daily gains.
- Regeneron Pharmaceuticals Inc (REGN: NASDAQ) shares are up more than 6%.
- Major cruise liner stocks are posting heavy losses.
The S&P 500 Index (SPX) started the new week sharply higher on positive developments surrounding US President Donald Trump's condition and preserved its bullish momentum. As of writing, the SPX was up 1.22% on the day at 3,390.
S&P 500 top movers
Late on Friday, Trump's doctor told reporters that the president was given an intravenous dose of Regeneron Pharmaceuticals Inc's (REGN: NASDAQ) experimental "antibody cocktail." Boosted by this development, REGN jumped to its highest level in five weeks at $619.97 after the opening bell but struggled to push higher. Nevertheless, REGN is still the largest daily percentage gainer, rising 6.2% near $600.
Among the other top performers of the day, Albemarle Corp (ALB: NYSE), United Rentals Inc (URI: NYSE) and Comerica Inc (CMA: NYSE) shares are all up around 6%.
On the other hand, major cruise liners shares are suffering heavy losses despite the upbeat market mood. Last week, the US Centers for Disease Control and Prevention (CDC) announced that it extended its ban on passenger cruises until at least November. At the moment, Norwegian Cruise Line Holdings Ltd (NCLH: NYSE) and Carnival Corp (CCL: NYSE) shares are down 3.2% and 2.3% respectively.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.